News

NCBIO Member Event of InterestPSC Biotech Announces The Art and Science of Naming Drugs and Medical Devices Jan. 27 and Feb. 3 1 p.m. via Webex  BIO's preferred partner, PSC Biotech, and the Brand Institute are pleased to bring you a webinar series, "The Art and Science of Naming Drugs and Medical Devices." The two-part series will focus on technical and strategic considerations and the ...read more

 Submit Your Application NowApplications are due Friday, Jan. 15 for the MedTech Innovator 2021 program. This is a highly selective and unique opportunity for startups and scale-ups to be showcased and gain access to health care stakeholders. These stakeholders include investors, customers and industry leaders from companies such as Johnson & Johnson, Baxter, Olympus, W. ...read more

 Submit Your Application NowApplications are now being accepted for the MedTech Innovator 2021 program. This is a highly selective and unique opportunity for startups and scale-ups to be showcased and gain access to health care stakeholders. These stakeholders include investors, customers and industry leaders from companies such as Johnson & Johnson, Baxter, Olympus, W. ...read more

Building a pipeline of diversity and establishing inclusivity as a core organizational value were among the topics discussed by panelists during the last installment of LaunchBio's webinar series, Let's Talk About, for 2020. The presentation, "The Right Track | Increasing Inclusivity in 2021," was held Wednesday, Dec. 9. Panelists included Jordyne Blaise, J.D., director of diversity equity and ...read more

NCBIO has named David Etchison as its new communications director. Etchison has more than 25 years of experience in communications, public relations and marketing. He served as director of communications for the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill for 15 years and most recently ran email marketing for UNC-TV.  Etchison succeeds Brenda Summers, Ed.D., ...read more

A COVID-resilient environment and clinical trials was the topic of discussion at a virtual forum hosted by NCBIO November 19.  The concept of virtual or decentralized trials has been around for a while, but COVID-19 forced companies and the FDA to act. Biopharma, regulatory and CRO representatives shared their perspectives on decentralized trials, their challenges and limitations, and on COVID-19 ...read more

DURHAM, N.C. — Neal Fowler, CEO of Liquidia Technologies, has been named the new chairman of the NCBIO Board of Directors, and five new members have joined the board. New officers and the 2020-21 executive committee were elected at the board meeting Thursday, November 12.   “We are very pleased that Neal has agreed to serve as our board chair,” said Sam Taylor, president of NCBIO, the North ...read more

Four days of sessions on elections, policies, COVID-19 and more comprised the 2020 NCBIO Annual Meeting held Sept. 29 to Oct. 2.  “We are living through extraordinary challenges,” BIO CEO  Dr. Michelle McMurry-Heath said during the closing session of NCBIO Annual Meeting. “I  hope it is a turning point in the public’s understanding of why science matters. Biotech and science are the catalysts ...read more